Catalyst Wire Dossier Catalyst Wire Dossier

Rucaparib

rucaparib · Clovis Oncology
Drug timelines are a Plus or Pro feature.

28 regulatory and trial events tracked for Rucaparib, covering 2016-05-24 to 2026-02-05. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy [Phase 3]

See pricing